NZ299241A - Systemic delivery of parathyroid hormone by oral inhalation - Google Patents

Systemic delivery of parathyroid hormone by oral inhalation

Info

Publication number
NZ299241A
NZ299241A NZ299241A NZ29924196A NZ299241A NZ 299241 A NZ299241 A NZ 299241A NZ 299241 A NZ299241 A NZ 299241A NZ 29924196 A NZ29924196 A NZ 29924196A NZ 299241 A NZ299241 A NZ 299241A
Authority
NZ
New Zealand
Prior art keywords
parathyroid hormone
systemic delivery
oral inhalation
inhalation
oral
Prior art date
Application number
NZ299241A
Inventor
John S Patton
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of NZ299241A publication Critical patent/NZ299241A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The specification describes the pulsatile systemic delivery of parathyroid hormone and its use in the treatment of osteoporosis. The preferred PTH concentration range is from 1mg/ml to 20mg/ml.
NZ299241A 1992-09-29 1996-08-27 Systemic delivery of parathyroid hormone by oral inhalation NZ299241A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95339792A 1992-09-29 1992-09-29
NZ25721296 1996-08-27

Publications (1)

Publication Number Publication Date
NZ299241A true NZ299241A (en) 2000-11-24

Family

ID=26651305

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ299241A NZ299241A (en) 1992-09-29 1996-08-27 Systemic delivery of parathyroid hormone by oral inhalation

Country Status (1)

Country Link
NZ (1) NZ299241A (en)

Similar Documents

Publication Publication Date Title
CZ80395A3 (en) Pharmaceutical preparation
EG20599A (en) Powder preparation for inhalation
IL125534A0 (en) A unit dose of budesonide and use thereof for nasal administration
PL321094A1 (en) Parathyroid hormone (pth) containing preparation administered by inhalation
DE3583849D1 (en) USE OF INTERFERON GAMMA (IFN-GAMMA) CONTAINERS FOR THE SYSTEMIC TREATMENT OF VARIOUS DISEASES OF HUMAN IN LOW DOSAGE.
GR3030730T3 (en) Arrangement and method for dispensing preservative-free nasal sprays and similar preparations.
TNSN99038A1 (en) DELIVERY OF AN ATOMIZED ACTIVE AGENT
MY115688A (en) Pharmaceutical composition for administration by inhalation
HK1003980A1 (en) Dosage form for dispensing drug and human therapy
FI932385A0 (en) Behandling of the osteoporos genome by anatomical use of somatoliberin (GRF) in combination with parathyroid hormone (PTH)
EP0151989A3 (en) Means for the treatment of cardiac diseases
JPS6438020A (en) Therapy
EP1294375A4 (en) Method of treatment of seborrheic dermatitis
HU9402272D0 (en) Parathyroid hormone fragments, their preparation and medicaments containing the same
EP0222385A3 (en) Sex hormones for the treatment of immunodeficiency diseases
NZ299241A (en) Systemic delivery of parathyroid hormone by oral inhalation
AU1665992A (en) Novel taurine-based pharmaceutical composition for administration by inhalation
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
GB9309262D0 (en) Mask for the delivery of gases and vapours to breathing organisms
IT1247527B (en) ANTI-ARTERIOSCLEROTIC AGENT, ITS PREPARATION AND USE
ATE66375T1 (en) USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES.
UA7190A (en) Method for treating pyo-inflammatory processes in lungs
IT1240853B (en) Pharmaceutical compound administered nasally and containing calcitonin and a acylcarnitine
SU1807595A1 (en) Agent for treatment against mercury intoxication
BG94567A (en) Medicaments for the treatment of aids and method for its application

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired